GS
BNTX icon

GTS Securities’s BioNTech BNTX Stock Holding History

GTS Securities’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,937
Closed -$221K – 1247
2024
Q4 		$221K Sell
1,937
-49,248
-96% -$5.62M 0.01% 1059
2024
Q3 		$6.08M Buy
51,185
+40,031
+359% +$3.68M 0.01% 768
2024
Q2 		$896K Sell
11,154
-2,445
-18% -$223K ﹤0.01% 2151
2024
Q1 		$1.25M Sell
13,599
-4,801
-26% -$460K ﹤0.01% 1822
2023
Q4 		$1.94M Sell
18,400
-11,926
-39% -$1.2M ﹤0.01% 1677
2023
Q3 		$3.29M Sell
30,326
-28,127
-48% -$3.11M 0.01% 1182
2023
Q2 		$6.31M Buy
+58,453
New +$6.57M 0.2% 102

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

GTS Securities's BNTX Position: Q1 2025 in Review

GTS Securities sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 1,937 shares — an estimated $221K sold.

GTS Securities first reported a position in BNTX in Q2 2023 and held it in 7 quarters. The position peaked at $6.31M in Q2 2023. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • GTS Securities reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • GTS Securities sold 1,937 BioNTech shares in Q1 2025, an estimated $221K.
  • GTS Securities first reported a position in BioNTech in Q2 2023 and held it in 7 quarters.
  • GTS Securities's BioNTech position peaked at $6.31M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on GTS Securities's 13F filing for Q1 2025, filed 15 May 2025.